Agenus, Inc. (AGEN)
3.915
-0.12
(-2.85%)
USD |
NASDAQ |
Dec 09, 16:00
3.915
0.00 (0.00%)
After-Hours: 20:00
Agenus Total Liabilities (Quarterly): 514.76M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 77.11M |
| Armata Pharmaceuticals, Inc. | 185.10M |
| Bionano Genomics, Inc. | 29.26M |
| Twist Bioscience Corp. | 168.90M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 233.89M |
| Shareholders Equity (Quarterly) | -274.14M |
| Debt to Equity Ratio | -1.244 |
| Current Ratio | 0.4665 |
| Net Debt Paydown Yield | 11.18% |